In the in vivo study, tumor volume in the mice implanted with EGFRvIII+ and IL-13Rα2+ glioma cells increased significantly in comparison with the mice implanted with WT epidermal growth factor receptor (EGFR) glioma cells. The gene discussed is EGFR; the disease is central nervous system cancer.